The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Vitamin D and the risk of prostate cancer

    Researchers in the UK and Belgium reviewed the evidence.

    First, the details.

    • 25 studies were included.
    • Data were combined for a meta-analysis.

    And, the results.

    • There was no significant relationship between vitamin D intake, 25(OH)D, or 1,25(OH)2D and the risk of prostate cancer and the subcategory of aggressive prostate cancer.

    The bottom line?

    The authors concluded, “Published literature provides little evidence to support a major role of vitamin D in preventing prostate cancer or its progression.”

    In a broader review, researchers at Fred Hutchinson Cancer Research Center, in Seattle, Washington, reported, “There were no associations of any nutrient or supplement (including vitamin D) with prostate cancer risk overall.”

    2/16/11 21:14 JR

    Leave a Comment

    You must be logged in to post a comment.